EBERT CHARLES D 4
4 · WATSON PHARMACEUTICALS INC · Filed Jun 1, 2011
Insider Transaction Report
Form 4
EBERT CHARLES D
Sr. VP, Research & Development
Transactions
- Sale
Common Stock, par value $0.0033
2011-06-01$64.45/sh−2,635$169,826→ 27,722 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.45 to $64.46, inclusive. The reporting person undertakes to provide to Watson Pharmaceuticals, Inc., any security holder of Watson Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F2]Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.